The Program Leaders of the USC Norris Comprehensive Cancer Center (NCCC) promote both intra and inter-programmatic transdisciplinary research through careful selection of program members and recruitment of new faculty, coordination of interactions between program members and with other NCCC members, as well as facilitation and leadership of transdisciplinary and multi-project research applications, seminars, mini-symposia, program retreats and program meetings. This transdisciplinary emphasis is reinforced by having two leaders from different disciplines for most programs. For those programs with two leaders (Epigenetics and Regulation, Tumor Microenvironment, Cancer Epidemiology, Cancer Control Research, Developmental Therapeutics, Genitourinary Cancers, Gastrointestinal Cancers, Leukemia and Lymphoma and Women's Cancers) we are requesting support for 7.5% effort for each leader and for one program (Molecular Genetics) with one leader we are asking support for 10% effort.

Public Health Relevance

The Program Leaders facilitate scientific discoveries and coordinate activities to foster transdisciplinary research for the development of more effective prevention, diagnosis and treatment of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-37
Application #
8555585
Study Section
Subcommittee G - Education (NCI)
Project Start
1996-12-01
Project End
2015-11-30
Budget Start
2012-02-10
Budget End
2012-11-30
Support Year
37
Fiscal Year
2012
Total Cost
$412,880
Indirect Cost
$149,318
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Sebio, A; Stintzing, S; Heinemann, V et al. (2018) A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. Pharmacogenomics J 18:43-48
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Zhao, Yi; Wu, Kaijin; Wu, Yongfeng et al. (2018) Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists. Curr Mol Pharmacol 11:113-121
Kahn, Michael (2018) Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators. Prog Mol Biol Transl Sci 153:209-244
Park, Sungshim L; Patel, Yesha M; Loo, Lenora W M et al. (2018) Association of internal smoking dose with blood DNA methylation in three racial/ethnic populations. Clin Epigenetics 10:110
Liu, Jie; Liang, Gangning; Siegmund, Kimberly D et al. (2018) Data integration by multi-tuning parameter elastic net regression. BMC Bioinformatics 19:369
McDonnell, Kevin J; Chemler, Joseph A; Bartels, Phillip L et al. (2018) A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S]2+ cluster. Nat Chem 10:873-880
Schirripa, Marta; Zhang, Wu; Yang, Dongyun et al. (2018) NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients. PLoS One 13:e0193640

Showing the most recent 10 out of 842 publications